4
Changes in Ownership
Jazz Pharmaceuticals plc Filed Acc 0001765581-20-000109
Director sold 12,500 shares at an average $153.44 ($1,918,000)
- Director acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sohn Catherine A. · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-04 | Exercise or conversion : show line 1 in the form | +4,500 | $81.76 | $367,920 | 15,122 | D |
| 2020-11-04 | Sale : show line 2 in the form | −4,500 | $156.00 | $702,000 | 10,622 | D |
| 2020-11-04 | Exercise or conversion : show line 3 in the form | +8,000 | $46.83 | $374,640 | 18,622 | D |
| 2020-11-04 | Sale : show line 4 in the form | −8,000 | $152.00 | $1,216,000 | 10,622 | D |
| Open-market sales · 12,500 sh · avg $153.44 · $1,918,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-04 | Exercise or conversion : show line 5 in the form Non-Qualified Stock Option (right to buy) | −8,000 | 0 | D |
| 2020-11-04 | Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) | −4,500 | 0 | D |
Loading xslF345X03/edgardoc.xml…